EU, CureVac conclude talks for 225 million COVID-19 vaccine doses

On August 20, European Commission and German firm CureVac said that y h concluded first round of talks regarding supply of at least 225 million doses of a potential COVID-19 vaccine to EU states. According to contract between Commission and CureVac, donations will also be me to lower and middle income countries. Reports suggest that y are also in contact with Johnson & Johnson and Safi for ir vaccines which are in process of development. Last week, y also agreed on an vanced purchase deal with AstraZeneca for at least 300 million doses of shot it is developing with Oxford University.

Re: Russia Dismisses COVID-19 Vaccine Safety Concerns, Medics To Get Doses In Two Weeks

180 ditional doses to also be included

Ursula von der Leyen, EU Commission President reportedly said that each round of talks with pharmaceutical industry will bring m closer to battle vel coronavirus. Reports by international media suggest that on August 20, CureVac revealed that talks included an option to supply 180 million ditional doses. European Union will soon negotiate a contract with company leing to its first bilateral deal. deal will be aimed at acquiring vaccine for all EU member states.  company’s shares that soared as much as 222% rose almost 8% in premarket tre on August 20. 

Re: Mexico Needs 200 Million Coronavirus Vaccine Doses, To Start Shots In April 2021

EU officials reportedly said that  Commission was also in talks with U.S. biotech firm Moderna and German firm BioNtech as it is developing  a vaccine with U.S. pharmaceutical company Pfizer. According to reports, approach of CureVac is similar to Moderna and BionTech as it is completely based on RNA. RNA includes pieces of genetic code that encour human cells to produce proteins which are rapeutic. CureVac reportedly said that it could start a massive human trial on its vaccine in last quarter of this year. However, final decision will be me on basis of current trials. 

Re: China's CanSi Says Enrollment For Phase 3 Trials Of Its COVID-19 Vaccine Hasn't Begun

Also Re: WHO: Started Discussions With Russia On Vaccine

(Im Credits: PTI)